 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2025 |
|
 |
|
NEOGEN LAUNCHES IGENITY BCHF TO MITIGATE BOVINE CONGESTIVE HEART FAILURE RISK
Jan. 17, 2025
Source: Neogen news release
With unmatched commitment to serving the cattle industry with impactful herd health and genomic solutions, Neogen announces the launch of its Igenity BCHF to uplift overall bovine heart health standards. Bovine congestive heart failure (BCHF) stands as a significant threat to cattle health and productivity, and this new genomic test unveils opportunity for improved selection for heart health.
"Igenity BCHF is a revolutionary genomic test designed to assess an animal's genetic predisposition to heart failure," said Dr. Victor Pedrosa, director of Technical Genomics and Innovation with Neogen. "The test results directly correlate with the percentage of BCHF risk an animal carries and should pass on to their progeny, serving as a genetic indicator of the likelihood of disease development."
Testing with Igenity BCHF assesses animals' genetic predisposition for BCHF. Test results are scored on a 1-to-10 scale, ranging from 1 (lowest risk) to 10 (highest risk of symptom development), where each decrease in score translates to an expected 3.5% lower BCHF incidence. Case study results demonstrated the variability for risk in a feedlot setting, where animals with an Igenity score of 2 characterized a genetic effect of 3.5% for BCHF predisposition and animals with an Igenity score of 7 signified a genetic effect of 21.2% for BCHF predisposition. This demonstrated a 17.7% lower probability of exhibiting BCHF with an Igenity score decrease of 5.
To read entire report, Click Here.
|
|
|
|
|
